Clinical impact of minocycline on afatinib-related rash in patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
ConclusionsA large proportion of the study patients started minocycline before grade 2 rash development and the severity of afatinib-related rash was lower than that previously reported. Oral TCs may be beneficial, especially if started early.
Source: Respiratory Investigation - Category: Respiratory Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Minocycline | Non-Small Cell Lung Cancer | Oral Cancer | Respiratory Medicine | Skin | Solodyn | Study | Tetracycline | Toxicology